Skip to main content
Top
Published in: Intensive Care Medicine 8/2005

01-08-2005 | Experimental

Candesartan improves survival following severe hypovolemia in pigs; a role for the angiotensin II type 2 receptor?

Authors: Mats Laesser, Emma Spak, Sara Ewert, Anders Aneman, Lars Fandriks

Published in: Intensive Care Medicine | Issue 8/2005

Login to get access

Abstract

Objective

To investigate the involvement of intestinal angiotensin II type 2 receptors in the outcome of acute severe hypovolemia as well as systemic and regional mesenteric hemodynamics and intestinal mucosal functions in anesthetized pigs.

Design and setting

Prospective, interventional animal study in a university research laboratory.

Subjects

53 landrace pigs, 28–35 kg.

Interventions

30+30% or 20+20% hemorrhage of estimated total blood volume followed by retransfusion performed in untreated controls, in animals treated with the angiotensin II type 1 receptor blocker candesartan or with a combination of candesartan and the angiotensin II type 2 receptor blocker PD123319.

Measurements and results

Following 30+30% hemorrhage the candesartan-treated animals attained a significantly higher survival rate than controls and animals treated with PD123319 in combination with candesartan. Less pronounced hemorrhage (20+20%) resulted in no mortality and functional variables were assessed. A significantly higher output of jejunal intraluminal nitric oxide occurred during hypovolemia in the candesartan treated group than in controls and animals that received PD123319 in combination with candesartan. Jejunal transmucosal potential difference was significantly better preserved after retransfusion in candesartan-treated animals than in controls. Expression of angiotensin II type 2 receptors in intestinal tissue was significantly higher in animals surviving the 30+30% hemorrhage than in nonsurvivors.

Conclusions

Lethal circulatory failure is possibly influenced by use of angiotensin receptor ligands, and activation of intestinal angiotensin II type 2 receptors may play a significant role in improving the outcome of severe hypovolemia.
Literature
1.
go back to reference Swank GM, Deitch EA (1996) Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20:411–417CrossRefPubMed Swank GM, Deitch EA (1996) Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20:411–417CrossRefPubMed
2.
go back to reference Landow L, Andersen LW (1994) Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 38:626–639 Landow L, Andersen LW (1994) Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 38:626–639
3.
go back to reference Toung T, Reilly PM, Fuh KC, Ferris R, Bulkley GB (2000) Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 13:267–273PubMed Toung T, Reilly PM, Fuh KC, Ferris R, Bulkley GB (2000) Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 13:267–273PubMed
4.
go back to reference Kuebler JF, Jarrar D, Toth B, Bland KI, Rue L, 3rd, Wang P, Chaudry IH (2002) Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137:74–79CrossRefPubMed Kuebler JF, Jarrar D, Toth B, Bland KI, Rue L, 3rd, Wang P, Chaudry IH (2002) Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137:74–79CrossRefPubMed
5.
go back to reference Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y (2002) Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71:381–388CrossRefPubMed Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y (2002) Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71:381–388CrossRefPubMed
6.
go back to reference Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A (2003) Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 21:1429–1443CrossRefPubMed Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A (2003) Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 21:1429–1443CrossRefPubMed
7.
go back to reference Laesser M, Fandriks L, Pettersson A, Ewert S, Aneman A (2000) Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. Shock 14:471–477PubMed Laesser M, Fandriks L, Pettersson A, Ewert S, Aneman A (2000) Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. Shock 14:471–477PubMed
8.
go back to reference Aneman A, Svensson M, Broome M, Biber B, Petterson A, Fandriks L (2000) Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs. Crit Care Med 28:818–823 Aneman A, Svensson M, Broome M, Biber B, Petterson A, Fandriks L (2000) Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs. Crit Care Med 28:818–823
9.
go back to reference Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J, Rudehill A (1999) Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 11:127–135PubMed Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J, Rudehill A (1999) Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 11:127–135PubMed
10.
go back to reference Widdop RE, Jones ES, Hannan RE, Gaspari TA (2003) Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140:809–824 Widdop RE, Jones ES, Hannan RE, Gaspari TA (2003) Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140:809–824
11.
go back to reference Carey RM, Jin X, Wang Z, Siragy HM (2000) Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 168:65–71 Carey RM, Jin X, Wang Z, Siragy HM (2000) Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 168:65–71
12.
go back to reference Siragy HM, Carey RM (1999) Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33:1237–1242PubMed Siragy HM, Carey RM (1999) Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33:1237–1242PubMed
13.
go back to reference Snygg J, Casselbrant A, Pettersson A, Holm M, Fandriks L, Aneman A (2000) Tonometric assessment of jejunal mucosal nitric oxide formation in anaesthetized pigs. Acta Physiol Scand 169:39–45CrossRefPubMed Snygg J, Casselbrant A, Pettersson A, Holm M, Fandriks L, Aneman A (2000) Tonometric assessment of jejunal mucosal nitric oxide formation in anaesthetized pigs. Acta Physiol Scand 169:39–45CrossRefPubMed
14.
go back to reference Ewert S, Laesser M, Johansson B, Holm M, Aneman A, Fandriks L (2003) The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa. BMC Pharmacol 3:2CrossRefPubMed Ewert S, Laesser M, Johansson B, Holm M, Aneman A, Fandriks L (2003) The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa. BMC Pharmacol 3:2CrossRefPubMed
15.
go back to reference Engelhardt V (1966) Swine cardiovascular physiology—a review. In: Bustard LK (ed) MR swine in biomedical research. Frayn, Seattle, pp 307–329 Engelhardt V (1966) Swine cardiovascular physiology—a review. In: Bustard LK (ed) MR swine in biomedical research. Frayn, Seattle, pp 307–329
16.
go back to reference Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238–1246PubMed Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238–1246PubMed
17.
go back to reference Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMed Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMed
18.
go back to reference Aneman A, Pettersson A, Eisenhofer G, Friberg P, Holm M, von Bothmer C, Fandriks L (1997) Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock 8:378–384PubMed Aneman A, Pettersson A, Eisenhofer G, Friberg P, Holm M, von Bothmer C, Fandriks L (1997) Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock 8:378–384PubMed
19.
go back to reference Abdelrahman AM, Burrell LM, Johnston CI (1993) Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. J Hypertens Suppl 11:S23–S26PubMed Abdelrahman AM, Burrell LM, Johnston CI (1993) Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. J Hypertens Suppl 11:S23–S26PubMed
20.
go back to reference Millatt LJ, Abdel-Rahman EM, Siragy HM (1999) Angiotensin II and nitric oxide: a question of balance. Regul Pept 81:1–10CrossRefPubMed Millatt LJ, Abdel-Rahman EM, Siragy HM (1999) Angiotensin II and nitric oxide: a question of balance. Regul Pept 81:1–10CrossRefPubMed
21.
go back to reference Wallace JL, Miller MJ (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119:512–520PubMed Wallace JL, Miller MJ (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119:512–520PubMed
22.
go back to reference Izzo AA, Mascolo N, Capasso F (1998) Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43:1605–1620CrossRefPubMed Izzo AA, Mascolo N, Capasso F (1998) Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43:1605–1620CrossRefPubMed
23.
go back to reference Snygg J, Aneman A, Pettersson A, Fandriks L (2000) Jejunal mucosal nitric oxide production and substrate dependency during acute mesenteric hypoperfusion in pigs. Crit Care Med 28:2563–2566 Snygg J, Aneman A, Pettersson A, Fandriks L (2000) Jejunal mucosal nitric oxide production and substrate dependency during acute mesenteric hypoperfusion in pigs. Crit Care Med 28:2563–2566
24.
go back to reference Snygg J, Fandriks L, Bengtsson J, Holm M, Pettersson A, Aneman A (2001) Jejunal luminal nitric oxide during severe hypovolemia and sepsis in anesthetized pigs. Intensive Care Med 27:1807–1813CrossRefPubMed Snygg J, Fandriks L, Bengtsson J, Holm M, Pettersson A, Aneman A (2001) Jejunal luminal nitric oxide during severe hypovolemia and sepsis in anesthetized pigs. Intensive Care Med 27:1807–1813CrossRefPubMed
25.
go back to reference Hojgaard L (1991) Gastric potential difference measurements. The gastric mucosal integrity and function studied with a new method for measurement of the electric potential difference across the stomach wall. Scand J Gastroenterol Suppl 184:1–27PubMed Hojgaard L (1991) Gastric potential difference measurements. The gastric mucosal integrity and function studied with a new method for measurement of the electric potential difference across the stomach wall. Scand J Gastroenterol Suppl 184:1–27PubMed
26.
go back to reference Newton CR, Curran B, Victorino GP (2004) Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability. Surgery 136:1054–1060CrossRefPubMed Newton CR, Curran B, Victorino GP (2004) Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability. Surgery 136:1054–1060CrossRefPubMed
Metadata
Title
Candesartan improves survival following severe hypovolemia in pigs; a role for the angiotensin II type 2 receptor?
Authors
Mats Laesser
Emma Spak
Sara Ewert
Anders Aneman
Lars Fandriks
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2005
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2686-1

Other articles of this Issue 8/2005

Intensive Care Medicine 8/2005 Go to the issue

Correspondence

Authors’ reply